Breast cancer drug trial of trastuzumab biosimilar gets positive CHMP

Breast cancer drug trial of trastuzumab biosimilar gets positive CHMP

JHL Biotech has announced it received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) related to the EU approval pathway for its proposed trastuzumab biosimilar, JHL1188, to treat breast cancer. The reference biologic trastuzumab is a humanised monoclonal antibody designed to target and […]

Anti-cancer drug kills man being treated for a broken bone

Anti-cancer drug kills man being treated for a broken bone

SHIMONOSEKI, Yamaguchi Prefecture–Doctors and pharmacists at a local hospital here unwittingly caused the death of an elderly man admitted with a leg fracture by administering a strong anti-cancer drug that can only be used for a few days. The patient, who was in his 70s, had been treated at another hospital for a brain tumor. […]

India's Hetero pulls heart drug from US amid cancer risk probes

India's Hetero pulls heart drug from US amid cancer risk probes

MUMBAI, Aug 11 (Reuters) – A unit of India’s Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S. regulator’s website said, amid a wider probe into cancer risks associated with the drug. At least a dozen companies around the world have […]

Chinese Heart Drugs Linked to Cancer Recalled Across Europe

Chinese Heart Drugs Linked to Cancer Recalled Across Europe

Europe 02:14 11.08.2018(updated 02:17 11.08.2018) Get short URL The European Medicines Agency (EMA) issued a recall Friday of a series of drugs used to treat high blood pressure and heart conditions that contain a chemical with an impurity that might cause cancer. N-nitrosodimethylamine (NDMA), a probable human carcinogen, was discovered in the valsartan medication that is […]

Bexion Pharmaceuticals Early-Stage Cancer Drug Being Hailed as Game Changer

Bexion Pharmaceuticals Early-Stage Cancer Drug Being Hailed as Game Changer

Bexion Pharmaceuticals is not a household name as far as drugmakers go. But, this week the company and its investigational cancer treatment, BXQ-350, is receiving lots of mainstream media coverage as a potential game-changer. BXQ-350 is a formulation of a synthetically produced, human lysosomal protein, Saposin C (sphingolipid activator protein, or SapC), and the phospholipid dioleoylphosphatidylserine […]

Cipla arm secures marketing rights for cancer drug in US

Cipla arm secures marketing rights for cancer drug in US

Drug major Cipla today said its subsidiary has secured rights from Hyderabad-based MSN Laboratories to market and distribute colon cancer treatment drug Capecitabine in the US market. Cipla USA, Inc, a subsidiary of the company will be marketing the drug in strengths of 150 and 500 mg tablets. The company’s product is generic equivalent of […]

China's Drugs Problem Spells Opportunity for Pharma Giants

China's Drugs Problem Spells Opportunity for Pharma Giants

Aug. 10, 2018 7:56 a.m. ET Despite escalating global trade tensions, there is at least one area in which China is still opening up—pharmaceuticals. The country’s Center for Drug Evaluation, China’s version of the Food & Drug Administration, this week made 48 drugs that have already been approved by regulators in the U.S., Japan or […]

Provinces race to find money for cancer drug

Provinces race to find money for cancer drug

Provinces are scrambling to find resources to fund Roche’s breast cancer drug trastuzumab after the health department approved a policy to provide it without securing additional funding. As a result, the Western Cape has opted not to provide the drug at this stage, saying to do so would mean depriving other patients of services. Provinces […]